BMJ-TAG conducts research to support the role of the National Institute for Health and Care Excellence (NICE) and other policy makers in the UK to improve health outcomes. Through the Technology Assessment Review (TAR) programme, BMJ-TAG and eight other research teams support NICE by conducting independent research about the clinical- and cost-effectiveness of new medicines, devices and diagnostic tests for use in the NHS. The TAR programme is managed by the National Institute for Health Research (NIHR) through their Evaluation, Trials and Studies Coordinating Centre (NETSCC).
Most work conducted by BMJ-TAG for NICE is for Single Technology Appraisals (STA), which assess the clinical and economic evidence for a single medicine or treatment for a single indication. Our role in the STA process is to provide an independent report based on evidence submitted by a pharmaceutical company (see diagram below), to help NICE Appraisal Committees make informed recommendations to the Department of Health and Social Care.
Other forms of NICE guidance that BMJ-TAG are involved with through the NIHR HTA programme are: